(215) 792-6676

Ocular Therapeutix – Securities Investigation

Ocular Therapeutix – Securities Investigation

//
Posted By
/
Comment0
/

Kehoe Law Firm’s securities attorneys are investigating potential claims on behalf of investors of Ocular Therapeutix, Inc. (NASDAQ: OCUL) regarding allegations that the company misled investors about issues with its manufacturing and testing procedures.

More Than 25% Stock Drop on Allegations of Ongoing Ocular Therapeutix Manufacturing Problems

Ocular Therapeutix disclosed on May 5, 2017 that it received a Form 483 from the U.S. Food and Drug Administration containing “inspectional observations” related to the Company’s manufacturing and analytical testing procedures.

On July 6, 2017, shortly before the end of the trading day, Seeking Alpha published an article reporting that the Ocular Therapeutix management had misled investors regarding the severity of ongoing manufacturing issues and downplayed the significance of FDA communications regarding these issues.

Following this news, Ocular’s share price fell 6% on July 6, 2017, and plummeted an additional 25% on July 7, 2017 to $7.12, causing significant harm to investors.

Do You Have Ocular Therapeutix Losses?

If you purchased or otherwise acquired shares in Ocular Therapeutix and would like to speak privately with a securities attorney to learn more about the investigation, fill out the form to the right or contact John Kehoe, Esq., (215) 792-6676, Ext. 801, [email protected]; Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected]; or send an e-mail to [email protected].

About Kehoe Law Firm, P.C.

The Kehoe Law Firm, P.C. is a multidisciplinary, plaintiff–side law firm dedicated to protecting investors and consumers from corporate fraud, negligence, and other wrongdoing. Driven by a strong and principled sense of social responsibility and obtaining justice for the aggrieved, Kehoe Law Firm, P.C. represents plaintiffs seeking to recover investment losses resulting from securities fraud, breaches of fiduciary duty, corporate wrongdoing or malfeasance, those harmed by anticompetitive practices, and consumers victimized by fraud, false claims, deception or data breaches.  Together, the partners of the Kehoe Law Firm, P.C. have spent more than 30 years prosecuting precedent-setting securities and financial fraud cases in federal and state courts on behalf of institutional and individual clients.